Fisher & Paykel Healthcare is a long-term play

Fisher & Paykel Healthcare is a long-term play
Chief executive Lewis Gradon (Image: Fisher & Paykel Healthcare)
Rebecca Howard
Fisher & Paykel Healthcare will benefit from the fact that its nasal high-flow therapy machine became the frontline choice for covid-19, but it won’t happen overnight. “The only real thing that covid-19 changed is that customers have a lot of the hardware,” said chief executive Lewis Gradon. Revenue in the year to March 31, 2019, was just over $1 billion. By the 2021 financial year, it had jumped to nearly $2b as the company moved swiftly to supply hospitals around the world with nasal high-flow therapy mach...

More Markets

Gamification – it’s coming for you
Opinion

Simon Robertson: Gamification – it’s coming for you

How smart companies game your life to make money.

Simon Robertson 01 Nov 2025
NZ stocks end firm after Sky, Vulcan, annual meetings
Markets Market Close

NZ stocks end firm after Sky, Vulcan, annual meetings

There were 84 rises and 54 falls on the main board.

Jamie Gray 31 Oct 2025
Rising volumes push Port of Tauranga profit outlook higher
Primary Sector

Rising volumes push Port of Tauranga profit outlook higher

Port of Tauranga expects its full-year net profit after tax to fall somewhere between $137 million and $147m.The NZX-listed port company’s container volumes increased 9% to 319,649 TEUs in the first three months to Sept 30.Total trade increased 5.9% in volume compared to the same...

Staff reporters 31 Oct 2025
SkyCity faces Adelaide reckoning by year-end
Markets

SkyCity faces Adelaide reckoning by year-end

Casino operator releases details about regulatory situation in Adelaide.

Dileepa Fonseka 31 Oct 2025